APO Research
Talk to an analyst

APO RESEARCH · REPORT

Closed Drug Transfer Systems

Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.

Selected research

Market Outlook & Growth Opportunities

Global Closed Drug Transfer Systems Market Outlook and Growth Opportunities 2026

21 December 2025199 pages

Choose your research edition.

Industry ResearchClosed Drug Transfer Systems Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Closed Drug Transfer Systems Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Closed Drug Transfer Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Closed Drug Transfer Systems Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Closed Drug Transfer Systems Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.

North America is the largest Closed Drug Transfer Systems market with about 73% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical etc. Top 3 companies occupied about 74% market share.

This report provides an overview of the global Closed Drug Transfer Systems market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Closed Drug Transfer Systems and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Closed Drug Transfer Systems revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Closed Drug Transfer Systems market.

Closed Drug Transfer Systems Segment by Company

BD Medical, Inc

Equashield, LLC

ICU Medical, Inc

Teva Medical Ltd

Corvida Medical

Closed Drug Transfer Systems Segment by Type

Closed Vial Access Devices

Closed Syringe Safety Devices

Closed Bag/Line Access Devices

Closed Drug Transfer Systems Segment by Application

Hospital

Clinic

Closed Drug Transfer Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Closed Drug Transfer Systems status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Closed Drug Transfer Systems key companies, revenue, market share, and recent developments.

3. To split the Closed Drug Transfer Systems breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Closed Drug Transfer Systems market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Closed Drug Transfer Systems significant trends, drivers, influence factors in global and regions.

6. To analyze Closed Drug Transfer Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Closed Drug Transfer Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Closed Drug Transfer Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Closed Drug Transfer Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Closed Drug Transfer Systems industry.

Chapter 3: Detailed analysis of Closed Drug Transfer Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Closed Drug Transfer Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Closed Drug Transfer Systems in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Closed Drug Transfer Systems Industry Trends Table 2. Closed Drug Transfer Systems Industry Drivers Table 3. Closed Drug Transfer Systems Industry Opportunities and Challenges Table 4. Closed Drug Transfer Systems Industry Restraints Table 5. Global Closed Drug Transfer Systems Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Closed Drug Transfer Systems Revenue Share by Company (2021-2026) Table 7. Global Closed Drug Transfer Systems Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Closed Drug Transfer Systems Key Company Manufacturing Base & Headquarters Table 9. Global Closed Drug Transfer Systems Company, Product Type & Application Table 10. Global Closed Drug Transfer Systems Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Closed Drug Transfer Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Closed Vial Access Devices Table 15. Significant Companies of Closed Syringe Safety Devices Table 16. Significant Companies of Closed Bag/Line Access Devices Table 17. Global Closed Drug Transfer Systems Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Closed Drug Transfer Systems Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Closed Drug Transfer Systems Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Closed Drug Transfer Systems Sales Value Share by Type (2021-2026) Table 21. Global Closed Drug Transfer Systems Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Clinic Table 24. Global Closed Drug Transfer Systems Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Closed Drug Transfer Systems Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Closed Drug Transfer Systems Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Closed Drug Transfer Systems Sales Value Share by Application (2021-2026) Table 28. Global Closed Drug Transfer Systems Sales Value Share by Application (2027-2032) Table 29. Global Closed Drug Transfer Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Closed Drug Transfer Systems Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Closed Drug Transfer Systems Sales Value Share by Region (2021-2026) Table 32. Global Closed Drug Transfer Systems Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Closed Drug Transfer Systems Sales Value Share by Region (2027-2032) Table 34. Global Closed Drug Transfer Systems Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Closed Drug Transfer Systems Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Closed Drug Transfer Systems Sales Value Market Share by Country (2021-2026) Table 37. Global Closed Drug Transfer Systems Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Closed Drug Transfer Systems Sales Value Market Share by Country (2027-2032) Table 39. BD Medical, Inc Company Information Table 40. BD Medical, Inc Business Overview Table 41. BD Medical, Inc Closed Drug Transfer Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. BD Medical, Inc Closed Drug Transfer Systems Product Portfolio Table 43. BD Medical, Inc Recent Development Table 44. Equashield, LLC Company Information Table 45. Equashield, LLC Business Overview Table 46. Equashield, LLC Closed Drug Transfer Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Equashield, LLC Closed Drug Transfer Systems Product Portfolio Table 48. Equashield, LLC Recent Development Table 49. ICU Medical, Inc Company Information Table 50. ICU Medical, Inc Business Overview Table 51. ICU Medical, Inc Closed Drug Transfer Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. ICU Medical, Inc Closed Drug Transfer Systems Product Portfolio Table 53. ICU Medical, Inc Recent Development Table 54. Teva Medical Ltd Company Information Table 55. Teva Medical Ltd Business Overview Table 56. Teva Medical Ltd Closed Drug Transfer Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Teva Medical Ltd Closed Drug Transfer Systems Product Portfolio Table 58. Teva Medical Ltd Recent Development Table 59. Corvida Medical Company Information Table 60. Corvida Medical Business Overview Table 61. Corvida Medical Closed Drug Transfer Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Corvida Medical Closed Drug Transfer Systems Product Portfolio Table 63. Corvida Medical Recent Development Table 64. Research Programs/Design for This Report Table 65. Authors List of This Report Table 66. Secondary Sources Table 67. Primary Sources List of Figures Figure 1. Closed Drug Transfer Systems Product Image Figure 2. Global Closed Drug Transfer Systems Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Closed Drug Transfer Systems Market Size (2021-2032) & (US$ Million) Figure 4. Global Closed Drug Transfer Systems Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Closed Vial Access Devices Image Figure 8. Closed Syringe Safety Devices Image Figure 9. Closed Bag/Line Access Devices Image Figure 10. Global Closed Drug Transfer Systems Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Closed Drug Transfer Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Closed Drug Transfer Systems Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Clinic Image Figure 15. Global Closed Drug Transfer Systems Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Closed Drug Transfer Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Closed Drug Transfer Systems Sales Value Share by Application (2021-2032) Figure 18. Global Closed Drug Transfer Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Closed Drug Transfer Systems Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Closed Drug Transfer Systems Sales Value (2021-2032) & (US$ Million) Figure 21. North America Closed Drug Transfer Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Closed Drug Transfer Systems Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Closed Drug Transfer Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Closed Drug Transfer Systems Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Closed Drug Transfer Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Closed Drug Transfer Systems Sales Value (2021-2032) & (US$ Million) Figure 27. South America Closed Drug Transfer Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Closed Drug Transfer Systems Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Closed Drug Transfer Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Closed Vial Access Devices
  • Closed Syringe Safety Devices
  • Closed Bag/Line Access Devices
Applications
  • Hospital
  • Clinic
Companies covered
  • BD Medical, Inc
  • Equashield, LLC
  • ICU Medical, Inc
  • Teva Medical Ltd
  • Corvida Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Closed Drug Transfer Systems Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Closed Drug Transfer Systems Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Closed Drug Transfer Systems Market Dynamics
  1. 2.1 Closed Drug Transfer Systems Industry Trends
  2. 2.2 Closed Drug Transfer Systems Industry Drivers
  3. 2.3 Closed Drug Transfer Systems Industry Opportunities and Challenges
  4. 2.4 Closed Drug Transfer Systems Industry Restraints
3 Closed Drug Transfer Systems Market by Company
  1. 3.1 Global Closed Drug Transfer Systems Company Revenue Ranking in 2025
  2. 3.2 Global Closed Drug Transfer Systems Revenue by Company (2021-2026)
  3. 3.3 Global Closed Drug Transfer Systems Company Ranking (2024-2026)
  4. 3.4 Global Closed Drug Transfer Systems Company Manufacturing Base and Headquarters
  5. 3.5 Global Closed Drug Transfer Systems Company Product Type and Application
  6. 3.6 Global Closed Drug Transfer Systems Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Closed Drug Transfer Systems Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Closed Drug Transfer Systems Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Closed Drug Transfer Systems Market by Type
  1. 4.1 Closed Drug Transfer Systems Type Introduction
  2. 4.1.1 Closed Vial Access Devices
  3. 4.1.2 Closed Syringe Safety Devices
  4. 4.1.3 Closed Bag/Line Access Devices
  5. 4.2 Global Closed Drug Transfer Systems Sales Value by Type
  6. 4.2.1 Global Closed Drug Transfer Systems Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Closed Drug Transfer Systems Sales Value by Type (2021-2032)
  8. 4.2.3 Global Closed Drug Transfer Systems Sales Value Share by Type (2021-2032)
5 Closed Drug Transfer Systems Market by Application
  1. 5.1 Closed Drug Transfer Systems Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Closed Drug Transfer Systems Sales Value by Application
  5. 5.2.1 Global Closed Drug Transfer Systems Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Closed Drug Transfer Systems Sales Value by Application (2021-2032)
  7. 5.2.3 Global Closed Drug Transfer Systems Sales Value Share by Application (2021-2032)
6 Closed Drug Transfer Systems Regional Value Analysis
  1. 6.1 Global Closed Drug Transfer Systems Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Closed Drug Transfer Systems Sales Value by Region (2021-2032)
  3. 6.2.1 Global Closed Drug Transfer Systems Sales Value by Region: 2021-2026
  4. 6.2.2 Global Closed Drug Transfer Systems Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Closed Drug Transfer Systems Sales Value (2021-2032)
  7. 6.3.2 North America Closed Drug Transfer Systems Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Closed Drug Transfer Systems Sales Value (2021-2032)
  10. 6.4.2 Europe Closed Drug Transfer Systems Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Closed Drug Transfer Systems Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Closed Drug Transfer Systems Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Closed Drug Transfer Systems Sales Value (2021-2032)
  16. 6.6.2 South America Closed Drug Transfer Systems Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Closed Drug Transfer Systems Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Closed Drug Transfer Systems Sales Value Share by Country, 2025 VS 2032
7 Closed Drug Transfer Systems Country-level Value Analysis
  1. 7.1 Global Closed Drug Transfer Systems Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Closed Drug Transfer Systems Sales Value by Country (2021-2032)
  3. 7.2.1 Global Closed Drug Transfer Systems Sales Value by Country (2021-2026)
  4. 7.2.2 Global Closed Drug Transfer Systems Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Closed Drug Transfer Systems Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Closed Drug Transfer Systems Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Closed Drug Transfer Systems Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BD Medical, Inc
  2. 8.1.1 BD Medical, Inc Company Information
  3. 8.1.2 BD Medical, Inc Business Overview
  4. 8.1.3 BD Medical, Inc Closed Drug Transfer Systems Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BD Medical, Inc Closed Drug Transfer Systems Product Portfolio
  6. 8.1.5 BD Medical, Inc Recent Developments
  7. 8.2 Equashield, LLC
  8. 8.2.1 Equashield, LLC Company Information
  9. 8.2.2 Equashield, LLC Business Overview
  10. 8.2.3 Equashield, LLC Closed Drug Transfer Systems Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Equashield, LLC Closed Drug Transfer Systems Product Portfolio
  12. 8.2.5 Equashield, LLC Recent Developments
  13. 8.3 ICU Medical, Inc
  14. 8.3.1 ICU Medical, Inc Company Information
  15. 8.3.2 ICU Medical, Inc Business Overview
  16. 8.3.3 ICU Medical, Inc Closed Drug Transfer Systems Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ICU Medical, Inc Closed Drug Transfer Systems Product Portfolio
  18. 8.3.5 ICU Medical, Inc Recent Developments
  19. 8.4 Teva Medical Ltd
  20. 8.4.1 Teva Medical Ltd Company Information
  21. 8.4.2 Teva Medical Ltd Business Overview
  22. 8.4.3 Teva Medical Ltd Closed Drug Transfer Systems Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Teva Medical Ltd Closed Drug Transfer Systems Product Portfolio
  24. 8.4.5 Teva Medical Ltd Recent Developments
  25. 8.5 Corvida Medical
  26. 8.5.1 Corvida Medical Company Information
  27. 8.5.2 Corvida Medical Business Overview
  28. 8.5.3 Corvida Medical Closed Drug Transfer Systems Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Corvida Medical Closed Drug Transfer Systems Product Portfolio
  30. 8.5.5 Corvida Medical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst